APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avian Influenza Vaccines

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Selected research

Market Analysis & Forecast

Global Avian Influenza Vaccines Market Analysis and Forecast 2026-2032

21 December 2025205 pages

Choose your research edition.

Industry ResearchAvian Influenza Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Avian Influenza Vaccines Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Avian Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avian Influenza Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Avian Influenza Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Read the full market overview

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

This report presents an overview of global market for Avian Influenza Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Avian Influenza Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Avian Influenza Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Avian Influenza Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Avian Influenza Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Avian Influenza Vaccines sales, projected growth trends, production technology, application and end-user industry.

Avian Influenza Vaccines Segment by Company

Merial

QYH Biotech

DHN

HVRI

CEVA

Elanco (Lohmann )

Yebio

Zoetis

FATRO

Kyoto Biken

CAVAC

Ringpu Biology

Vaksindo

ChengDu Tecbond

Sindh Poultry Vaccine Centre

Merck Animal Health

Medion

Avimex Animal Health

JOVAC

Bio-Labs

Avian Influenza Vaccines Segment by Type

H5+H7 Avian Influenza Vaccines

H9 Avian Influenza Vaccines

Avian Influenza Vaccines Segment by Application

Chicken Avian Influenza Vaccines

Duck & Goose Avian Influenza Vaccines

Other

Avian Influenza Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avian Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avian Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avian Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Avian Influenza Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avian Influenza Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. H5+H7 Avian Influenza Vaccines Major Manufacturers Table 3. H9 Avian Influenza Vaccines Major Manufacturers Table 4. Global Avian Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chicken Avian Influenza Vaccines Major Manufacturers Table 6. Duck & Goose Avian Influenza Vaccines Major Manufacturers Table 7. Other Major Manufacturers Table 8. Avian Influenza Vaccines Industry Trends Table 9. Avian Influenza Vaccines Industry Drivers Table 10. Avian Influenza Vaccines Industry Opportunities and Challenges Table 11. Avian Influenza Vaccines Industry Restraints Table 12. Global Avian Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Avian Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Avian Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Avian Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Avian Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Avian Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 18. Global Avian Influenza Vaccines Sales by Region (2021-2026) & (M Doses) Table 19. Global Avian Influenza Vaccines Sales by Region (2027-2032) & (M Doses) Table 20. Global Avian Influenza Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Avian Influenza Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Avian Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Avian Influenza Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Avian Influenza Vaccines Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 27. Global Avian Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Avian Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Avian Influenza Vaccines Manufacturers, Product Type & Application Table 30. Global Avian Influenza Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Avian Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Avian Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Avian Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Avian Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 40. Global Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 41. Global Avian Influenza Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Avian Influenza Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Avian Influenza Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 44. Global Avian Influenza Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 45. Global Avian Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Avian Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Avian Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 51. Global Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 53. Global Avian Influenza Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Avian Influenza Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Avian Influenza Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Avian Influenza Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 57. Merial Company Information Table 58. Merial Business Overview Table 59. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 60. Merial Avian Influenza Vaccines Product Portfolio Table 61. Merial Recent Development Table 62. QYH Biotech Company Information Table 63. QYH Biotech Business Overview Table 64. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 65. QYH Biotech Avian Influenza Vaccines Product Portfolio Table 66. QYH Biotech Recent Development Table 67. DHN Company Information Table 68. DHN Business Overview Table 69. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 70. DHN Avian Influenza Vaccines Product Portfolio Table 71. DHN Recent Development Table 72. HVRI Company Information Table 73. HVRI Business Overview Table 74. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 75. HVRI Avian Influenza Vaccines Product Portfolio Table 76. HVRI Recent Development Table 77. CEVA Company Information Table 78. CEVA Business Overview Table 79. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 80. CEVA Avian Influenza Vaccines Product Portfolio Table 81. CEVA Recent Development Table 82. Elanco (Lohmann ) Company Information Table 83. Elanco (Lohmann ) Business Overview Table 84. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 85. Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio Table 86. Elanco (Lohmann ) Recent Development Table 87. Yebio Company Information Table 88. Yebio Business Overview Table 89. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 90. Yebio Avian Influenza Vaccines Product Portfolio Table 91. Yebio Recent Development Table 92. Zoetis Company Information Table 93. Zoetis Business Overview Table 94. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 95. Zoetis Avian Influenza Vaccines Product Portfolio Table 96. Zoetis Recent Development Table 97. FATRO Company Information Table 98. FATRO Business Overview Table 99. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 100. FATRO Avian Influenza Vaccines Product Portfolio Table 101. FATRO Recent Development Table 102. Kyoto Biken Company Information Table 103. Kyoto Biken Business Overview Table 104. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 105. Kyoto Biken Avian Influenza Vaccines Product Portfolio Table 106. Kyoto Biken Recent Development Table 107. CAVAC Company Information Table 108. CAVAC Business Overview Table 109. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 110. CAVAC Avian Influenza Vaccines Product Portfolio Table 111. CAVAC Recent Development Table 112. Ringpu Biology Company Information Table 113. Ringpu Biology Business Overview Table 114. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 115. Ringpu Biology Avian Influenza Vaccines Product Portfolio Table 116. Ringpu Biology Recent Development Table 117. Vaksindo Company Information Table 118. Vaksindo Business Overview Table 119. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 120. Vaksindo Avian Influenza Vaccines Product Portfolio Table 121. Vaksindo Recent Development Table 122. ChengDu Tecbond Company Information Table 123. ChengDu Tecbond Business Overview Table 124. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 125. ChengDu Tecbond Avian Influenza Vaccines Product Portfolio Table 126. ChengDu Tecbond Recent Development Table 127. Sindh Poultry Vaccine Centre Company Information Table 128. Sindh Poultry Vaccine Centre Business Overview Table 129. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 130. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio Table 131. Sindh Poultry Vaccine Centre Recent Development Table 132. Merck Animal Health Company Information Table 133. Merck Animal Health Business Overview Table 134. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 135. Merck Animal Health Avian Influenza Vaccines Product Portfolio Table 136. Merck Animal Health Recent Development Table 137. Medion Company Information Table 138. Medion Business Overview Table 139. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 140. Medion Avian Influenza Vaccines Product Portfolio Table 141. Medion Recent Development Table 142. Avimex Animal Health Company Information Table 143. Avimex Animal Health Business Overview Table 144. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 145. Avimex Animal Health Avian Influenza Vaccines Product Portfolio Table 146. Avimex Animal Health Recent Development Table 147. JOVAC Company Information Table 148. JOVAC Business Overview Table 149. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 150. JOVAC Avian Influenza Vaccines Product Portfolio Table 151. JOVAC Recent Development Table 152. Bio-Labs Company Information Table 153. Bio-Labs Business Overview Table 154. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 155. Bio-Labs Avian Influenza Vaccines Product Portfolio Table 156. Bio-Labs Recent Development Table 157. North America Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 160. North America Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 161. North America Avian Influenza Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 162. North America Avian Influenza Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 163. North America Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 166. North America Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 167. North America Avian Influenza Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 168. North America Avian Influenza Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 169. North America Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Avian Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Avian Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 173. North America Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 174. North America Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 175. North America Avian Influenza Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 176. North America Avian Influenza Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 177. United States Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 178. Canada Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 179. Mexico Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 180. Europe Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 183. Europe Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 184. Europe Avian Influenza Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 185. Europe Avian Influenza Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 186. Europe Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 189. Europe Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 190. Europe Avian Influenza Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 191. Europe Avian Influenza Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 192. Europe Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Avian Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Avian Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 196. Europe Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 197. Europe Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 198. Europe Avian Influenza Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 199. Europe Avian Influenza Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 200. Germany Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 201. France Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 202. U.K. Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Italy Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 204. Russia Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 205. Spain Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 206. Netherlands Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 207. Switzerland Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 208. Sweden Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Poland Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 210. China Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 211. China Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 212. China Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 213. China Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 214. China Avian Influenza Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 215. China Avian Influenza Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 216. China Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 217. China Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 218. China Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 219. China Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 220. China Avian Influenza Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 221. China Avian Influenza Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 222. Asia Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 223. Asia Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 224. Asia Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 225. Asia Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 226. Asia Avian Influenza Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 227. Asia Avian Influenza Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 228. Asia Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 229. Asia Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 230. Asia Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 231. Asia Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 232. Asia Avian Influenza Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 233. Asia Avian Influenza Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 234. Asia Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. Asia Avian Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. Asia Avian Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. Asia Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 238. Asia Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 239. Asia Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 240. Asia Avian Influenza Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 241. Asia Avian Influenza Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 242. Japan Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 243. South Korea Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 244. India Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 245. Australia Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 246. Taiwan Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 247. Southeast Asia Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 248. SAMEA Avian Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 249. SAMEA Avian Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 250. SAMEA Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 251. SAMEA Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 252. SAMEA Avian Influenza Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 253. SAMEA Avian Influenza Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 254. SAMEA Avian Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 255. SAMEA Avian Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 256. SAMEA Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 257. SAMEA Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 258. SAMEA Avian Influenza Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 259. SAMEA Avian Influenza Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 260. SAMEA Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. SAMEA Avian Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. SAMEA Avian Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. SAMEA Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 264. SAMEA Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 265. SAMEA Avian Influenza Vaccines Sales by Country (2027-2032) & (M Doses) Table 266. SAMEA Avian Influenza Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 267. SAMEA Avian Influenza Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 268. Brazil Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 269. Argentina Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Chile Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Colombia Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 272. Peru Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 273. Saudi Arabia Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 274. Israel Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 275. UAE Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 276. Turkey Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 277. Iran Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 278. Egypt Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 279. Key Raw Materials Table 280. Raw Materials Key Suppliers Table 281. Avian Influenza Vaccines Distributors List Table 282. Avian Influenza Vaccines Customers List Table 283. Research Programs/Design for This Report Table 284. Authors List of This Report Table 285. Secondary Sources Table 286. Primary Sources List of Figures Figure 1. Avian Influenza Vaccines Image Figure 2. Global Avian Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avian Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. H5+H7 Avian Influenza Vaccines Image Figure 5. H9 Avian Influenza Vaccines Image Figure 6. Global Avian Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Avian Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Chicken Avian Influenza Vaccines Image Figure 9. Duck & Goose Avian Influenza Vaccines Image Figure 10. Other Image Figure 11. Global Avian Influenza Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Avian Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Avian Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Avian Influenza Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Avian Influenza Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Avian Influenza Vaccines Sales (2021-2032) & (M Doses) Figure 17. Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 18. Global Avian Influenza Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Avian Influenza Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. Europe Avian Influenza Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. China Avian Influenza Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. Asia (Excluding China) Avian Influenza Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. South America, Middle East and Africa Avian Influenza Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. Global Avian Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Avian Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Avian Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Avian Influenza Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Avian Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 31. Global Avian Influenza Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Avian Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Avian Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Avian Influenza Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Avian Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 37. Global Avian Influenza Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Avian Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Avian Influenza Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Avian Influenza Vaccines Sales Share by Type (2021-2032) Figure 41. North America Avian Influenza Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Avian Influenza Vaccines Sales Share by Application (2021-2032) Figure 43. North America Avian Influenza Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Avian Influenza Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Avian Influenza Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Avian Influenza Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Avian Influenza Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Avian Influenza Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Avian Influenza Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Avian Influenza Vaccines Sales Share by Country (2021-2032) Figure 51. China Avian Influenza Vaccines Revenue Share by Type (2021-2032) Figure 52. China Avian Influenza Vaccines Sales Share by Type (2021-2032) Figure 53. China Avian Influenza Vaccines Revenue Share by Application (2021-2032) Figure 54. China Avian Influenza Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Avian Influenza Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Avian Influenza Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Avian Influenza Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Avian Influenza Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Avian Influenza Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Avian Influenza Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Avian Influenza Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Avian Influenza Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Avian Influenza Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Avian Influenza Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Avian Influenza Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Avian Influenza Vaccines Sales Share by Country (2021-2032) Figure 67. Avian Influenza Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Avian Influenza Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Applications
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other
Companies covered
  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco (Lohmann )
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
  • Medion
  • Avimex Animal Health
  • JOVAC
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Avian Influenza Vaccines Market by Type
  3. 1.2.1 Global Avian Influenza Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 H5+H7 Avian Influenza Vaccines
  5. 1.2.3 H9 Avian Influenza Vaccines
  6. 1.3 Avian Influenza Vaccines Market by Application
  7. 1.3.1 Global Avian Influenza Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chicken Avian Influenza Vaccines
  9. 1.3.3 Duck & Goose Avian Influenza Vaccines
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Avian Influenza Vaccines Market Dynamics
  1. 2.1 Avian Influenza Vaccines Industry Trends
  2. 2.2 Avian Influenza Vaccines Industry Drivers
  3. 2.3 Avian Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Avian Influenza Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Avian Influenza Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Avian Influenza Vaccines Revenue by Region
  3. 3.2.1 Global Avian Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Avian Influenza Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Avian Influenza Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Avian Influenza Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Avian Influenza Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Avian Influenza Vaccines Sales by Region
  9. 3.4.1 Global Avian Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Avian Influenza Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Avian Influenza Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Avian Influenza Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Avian Influenza Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Avian Influenza Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Avian Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Avian Influenza Vaccines Sales by Manufacturers
  6. 4.2.1 Global Avian Influenza Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Avian Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Avian Influenza Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Avian Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Avian Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Avian Influenza Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Avian Influenza Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Avian Influenza Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Avian Influenza Vaccines Tier 1, Tier 2, and Tier 3
5 Avian Influenza Vaccines Market by Type
  1. 5.1 Global Avian Influenza Vaccines Revenue by Type
  2. 5.1.1 Global Avian Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Avian Influenza Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Avian Influenza Vaccines Sales by Type
  6. 5.2.1 Global Avian Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Avian Influenza Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Avian Influenza Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Avian Influenza Vaccines Price by Type
6 Avian Influenza Vaccines Market by Application
  1. 6.1 Global Avian Influenza Vaccines Revenue by Application
  2. 6.1.1 Global Avian Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Avian Influenza Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Avian Influenza Vaccines Sales by Application
  6. 6.2.1 Global Avian Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Avian Influenza Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Avian Influenza Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Avian Influenza Vaccines Price by Application
7 Company Profiles
  1. 7.1 Merial
  2. 7.1.1 Merial Company Information
  3. 7.1.2 Merial Business Overview
  4. 7.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merial Avian Influenza Vaccines Product Portfolio
  6. 7.1.5 Merial Recent Developments
  7. 7.2 QYH Biotech
  8. 7.2.1 QYH Biotech Company Information
  9. 7.2.2 QYH Biotech Business Overview
  10. 7.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
  12. 7.2.5 QYH Biotech Recent Developments
  13. 7.3 DHN
  14. 7.3.1 DHN Company Information
  15. 7.3.2 DHN Business Overview
  16. 7.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 DHN Avian Influenza Vaccines Product Portfolio
  18. 7.3.5 DHN Recent Developments
  19. 7.4 HVRI
  20. 7.4.1 HVRI Company Information
  21. 7.4.2 HVRI Business Overview
  22. 7.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 HVRI Avian Influenza Vaccines Product Portfolio
  24. 7.4.5 HVRI Recent Developments
  25. 7.5 CEVA
  26. 7.5.1 CEVA Company Information
  27. 7.5.2 CEVA Business Overview
  28. 7.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CEVA Avian Influenza Vaccines Product Portfolio
  30. 7.5.5 CEVA Recent Developments
  31. 7.6 Elanco (Lohmann )
  32. 7.6.1 Elanco (Lohmann ) Company Information
  33. 7.6.2 Elanco (Lohmann ) Business Overview
  34. 7.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
  36. 7.6.5 Elanco (Lohmann ) Recent Developments
  37. 7.7 Yebio
  38. 7.7.1 Yebio Company Information
  39. 7.7.2 Yebio Business Overview
  40. 7.7.3 Yebio Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Yebio Avian Influenza Vaccines Product Portfolio
  42. 7.7.5 Yebio Recent Developments
  43. 7.8 Zoetis
  44. 7.8.1 Zoetis Company Information
  45. 7.8.2 Zoetis Business Overview
  46. 7.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
  48. 7.8.5 Zoetis Recent Developments
  49. 7.9 FATRO
  50. 7.9.1 FATRO Company Information
  51. 7.9.2 FATRO Business Overview
  52. 7.9.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 FATRO Avian Influenza Vaccines Product Portfolio
  54. 7.9.5 FATRO Recent Developments
  55. 7.10 Kyoto Biken
  56. 7.10.1 Kyoto Biken Company Information
  57. 7.10.2 Kyoto Biken Business Overview
  58. 7.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
  60. 7.10.5 Kyoto Biken Recent Developments
  61. 7.11 CAVAC
  62. 7.11.1 CAVAC Company Information
  63. 7.11.2 CAVAC Business Overview
  64. 7.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
  66. 7.11.5 CAVAC Recent Developments
  67. 7.12 Ringpu Biology
  68. 7.12.1 Ringpu Biology Company Information
  69. 7.12.2 Ringpu Biology Business Overview
  70. 7.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
  72. 7.12.5 Ringpu Biology Recent Developments
  73. 7.13 Vaksindo
  74. 7.13.1 Vaksindo Company Information
  75. 7.13.2 Vaksindo Business Overview
  76. 7.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
  78. 7.13.5 Vaksindo Recent Developments
  79. 7.14 ChengDu Tecbond
  80. 7.14.1 ChengDu Tecbond Company Information
  81. 7.14.2 ChengDu Tecbond Business Overview
  82. 7.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
  84. 7.14.5 ChengDu Tecbond Recent Developments
  85. 7.15 Sindh Poultry Vaccine Centre
  86. 7.15.1 Sindh Poultry Vaccine Centre Company Information
  87. 7.15.2 Sindh Poultry Vaccine Centre Business Overview
  88. 7.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
  90. 7.15.5 Sindh Poultry Vaccine Centre Recent Developments
  91. 7.16 Merck Animal Health
  92. 7.16.1 Merck Animal Health Company Information
  93. 7.16.2 Merck Animal Health Business Overview
  94. 7.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
  96. 7.16.5 Merck Animal Health Recent Developments
  97. 7.17 Medion
  98. 7.17.1 Medion Company Information
  99. 7.17.2 Medion Business Overview
  100. 7.17.3 Medion Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Medion Avian Influenza Vaccines Product Portfolio
  102. 7.17.5 Medion Recent Developments
  103. 7.18 Avimex Animal Health
  104. 7.18.1 Avimex Animal Health Company Information
  105. 7.18.2 Avimex Animal Health Business Overview
  106. 7.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
  108. 7.18.5 Avimex Animal Health Recent Developments
  109. 7.19 JOVAC
  110. 7.19.1 JOVAC Company Information
  111. 7.19.2 JOVAC Business Overview
  112. 7.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
  114. 7.19.5 JOVAC Recent Developments
  115. 7.20 Bio-Labs
  116. 7.20.1 Bio-Labs Company Information
  117. 7.20.2 Bio-Labs Business Overview
  118. 7.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
  120. 7.20.5 Bio-Labs Recent Developments
8 North America
  1. 8.1 North America Avian Influenza Vaccines Market Size by Type
  2. 8.1.1 North America Avian Influenza Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Avian Influenza Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Avian Influenza Vaccines Price by Type (2021-2032)
  5. 8.2 North America Avian Influenza Vaccines Market Size by Application
  6. 8.2.1 North America Avian Influenza Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Avian Influenza Vaccines Price by Application (2021-2032)
  9. 8.3 North America Avian Influenza Vaccines Market Size by Country
  10. 8.3.1 North America Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Avian Influenza Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Avian Influenza Vaccines Market Size by Type
  2. 9.1.1 Europe Avian Influenza Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Avian Influenza Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Avian Influenza Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Avian Influenza Vaccines Market Size by Application
  6. 9.2.1 Europe Avian Influenza Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Avian Influenza Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Avian Influenza Vaccines Market Size by Country
  10. 9.3.1 Europe Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Avian Influenza Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Avian Influenza Vaccines Market Size by Type
  2. 10.1.1 China Avian Influenza Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Avian Influenza Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Avian Influenza Vaccines Price by Type (2021-2032)
  5. 10.2 China Avian Influenza Vaccines Market Size by Application
  6. 10.2.1 China Avian Influenza Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Avian Influenza Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Avian Influenza Vaccines Market Size by Type
  2. 11.1.1 Asia Avian Influenza Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Avian Influenza Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Avian Influenza Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Avian Influenza Vaccines Market Size by Application
  6. 11.2.1 Asia Avian Influenza Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Avian Influenza Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Avian Influenza Vaccines Market Size by Country
  10. 11.3.1 Asia Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Avian Influenza Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Avian Influenza Vaccines Market Size by Type
  2. 12.1.1 SAMEA Avian Influenza Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Avian Influenza Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Avian Influenza Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Avian Influenza Vaccines Market Size by Application
  6. 12.2.1 SAMEA Avian Influenza Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Avian Influenza Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Avian Influenza Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Avian Influenza Vaccines Market Size by Country
  10. 12.3.1 SAMEA Avian Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Avian Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Avian Influenza Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Avian Influenza Vaccines Value Chain Analysis
  2. 13.1.1 Avian Influenza Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Avian Influenza Vaccines Production Mode & Process
  6. 13.2 Avian Influenza Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Avian Influenza Vaccines Distributors
  9. 13.2.3 Avian Influenza Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst